Bayer
BAYRY13.6401.11% ( +0.150 )
Bayer (BAYRY)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Cro...
- Open
- 13.390
- High
- 13.680
- Low
- 13.370
- Prev. Close
- 13.490
- Volume
- 678.44K
- Turnover
- 9.22M
- Avg Price
- 13.595
- Bid/Ask Ratio
- --
- Amplitude
- 2.30%
- 52wk High
- 15.230
- Volume Ratio
- 0.68
- Turnover Ratio
- 0.02%
Bayer Analyst Rating
View MoreForecast & Rating
Jul 14, 2026Price forecast
$15.2211.62%
Forecast & RatingBuy
4analysts
- Strong buy25.00%
- Buy25.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 4 hours ago
Bayer seeks China approval to expand Kerendia use to non-diabetic chronic kidney disease
- Market Beat · 5 hours ago
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Update
- PUBT · 1 day ago, 02:05 AM
Bayer plans 2027 launch of Bergkamen site-services operating unit
- Tip Ranks · 2 days ago, 12:35 PM
Pantginis Reiterates Buy on ENV-105’s Emerging Resistance-Reversal Profile and Bayer Collaboration; Price Target Maintained at $12
- PUBT · Jul 27 at 12:11 AM
DKSH agrees to buy Bayer’s Meliane oral contraceptive brand in 30 markets
- businessinsider · Jul 26 at 04:57 PM
SA Asks: How will Trump's new tariffs impact the EU trade deal?
